Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
Recruiting now · Not applicable
Conditions studied: Barrett Esophagus, Esophageal Adenocarcinoma
In brief
This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.
Key facts
- Study ID
- NCT03961945
- Run by
- Mayo Clinic
- People needed
- 1550
- Starts
- 2021-07-01
- Expected to finish
- 2030-07-30
- Last updated by the study team
- 2026-01-26
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.
Where it is running
- Mayo Clinic Rochester — Rochester, Minnesota, United States (enrolling)
- Mayo Clinic Health System-Eau Claire — Eau Claire, Wisconsin, United States (enrolling)
- Mayo Clinic Health Systems - Austin — Austin, Minnesota, United States (enrolling)
- Northwell Health — New Hyde Park, New York, United States
- Baylor Scott & White Research Institute — Dallas, Texas, United States
- Mayo Clinic Arizona — Scottsdale, Arizona, United States
- Mayo Clinic Health System-Franciscan Healthcare — La Crosse, Wisconsin, United States
- Mayo Clinic Jacksonville — Jacksonville, Florida, United States
- Mayo Clinic Health Systems - Mankato — Mankato, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.